JULIA ORIGÜEN SABATER-rekin lankidetzan egindako argitalpenak (8)

2021

  1. Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5

2020

  1. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort

    American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462

2018

  1. Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study

    Transplant International, Vol. 31, Núm. 2, pp. 187-197

  2. Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?

    Atherosclerosis, Vol. 269, pp. 204-210

2017

  1. Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation

    Transplant Infectious Disease, Vol. 19, Núm. 2

2016

  1. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options

    Transplant Infectious Disease, Vol. 18, Núm. 4, pp. 575-584

  2. Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial

    American Journal of Transplantation, Vol. 16, Núm. 10, pp. 2943-2953

2015

  1. Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case–control study

    Infection, Vol. 43, Núm. 4, pp. 413-422